Yunokawa M - Search Results

1

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.

Oaknin A, Gladieff L, Martínez-García J, Villacampa G, Takekuma M, De Giorgi U, Lindemann K, Woelber L, Colombo N, Duska L, Leary A, Godoy-Ortiz A, Nishio S, Angelergues A, Rubio MJ, Fariñas-Madrid L, Yamaguchi S, Lorusso D, Ray-Coquard I, Manso L, Joly F, Alarcón J, Follana P, Romero I, Lebreton C, Pérez-Fidalgo JA, Yunokawa M, Dahlstrand H, D'Hondt V, Randall LM; ENGOT-Cx10–GEICO 68-C–JGOG1084–GOG-3030 Investigators. Oaknin A, et al. Among authors: yunokawa m. Lancet. 2024 Jan 6;403(10421):31-43. doi: 10.1016/S0140-6736(23)02405-4. Epub 2023 Dec 1. Lancet. 2024. PMID: 38048793 Clinical Trial.

2

Expression of tumor-associated differentially expressed Gene-14 (TADG-14/KLK8) and its protein hK8 in uterine endometria and endometrial carcinomas.

Jin H, Nagai N, Shigemasa K, Gu L, Tanimoto H, Yunokawa M, Ohama K, Kudo Y, O'Brien TJ. Jin H, et al. Among authors: yunokawa m. Tumour Biol. 2006;27(5):274-82. doi: 10.1159/000094741. Epub 2006 Jul 28. Tumour Biol. 2006. PMID: 16888409

3

Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers.

Komatsu M, Hiyama K, Tanimoto K, Yunokawa M, Otani K, Ohtaki M, Hiyama E, Kigawa J, Ohwada M, Suzuki M, Nagai N, Kudo Y, Nishiyama M. Komatsu M, et al. Among authors: yunokawa m. Mol Cancer Ther. 2006 Mar;5(3):767-75. doi: 10.1158/1535-7163.MCT-05-0408. Mol Cancer Ther. 2006. PMID: 16546992

4

Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas.

Yunokawa M, Tanimoto K, Nakamura H, Nagai N, Kudo Y, Kawamoto T, Kato Y, Hiyama E, Hiyama K, Nishiyama M. Yunokawa M, et al. Oncol Rep. 2007 Apr;17(4):871-8. Oncol Rep. 2007. PMID: 17342330

5

Human mismatch repair gene, MLH1, is transcriptionally repressed by the hypoxia-inducible transcription factors, DEC1 and DEC2.

Nakamura H, Tanimoto K, Hiyama K, Yunokawa M, Kawamoto T, Kato Y, Yoshiga K, Poellinger L, Hiyama E, Nishiyama M. Nakamura H, et al. Among authors: yunokawa m. Oncogene. 2008 Jul 10;27(30):4200-9. doi: 10.1038/onc.2008.58. Epub 2008 Mar 17. Oncogene. 2008. PMID: 18345027 Free article.

6

A novel prediction score for predicting the baseline risk of recurrence of stage I-II endometrial carcinoma.

Takahashi K, Yunokawa M, Sasada S, Takehara Y, Miyasaka N, Kato T, Tamura K. Takahashi K, et al. Among authors: yunokawa m. J Gynecol Oncol. 2019 Jan;30(1):e8. doi: 10.3802/jgo.2019.30.e8. Epub 2018 Oct 2. J Gynecol Oncol. 2019. PMID: 30479092 Free PMC article.

7

Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.

Harano K, Hirakawa A, Yunokawa M, Nakamura T, Satoh T, Nishikawa T, Aoki D, Ito K, Ito K, Nakanishi T, Susumu N, Takehara K, Watanabe Y, Watari H, Saito T. Harano K, et al. Among authors: yunokawa m. Int J Clin Oncol. 2016 Feb;21(1):168-76. doi: 10.1007/s10147-015-0859-7. Epub 2015 Jun 18. Int J Clin Oncol. 2016. PMID: 26084780

8

UFT and its metabolite gamma-butyrolactone (GBL) inhibit angiogenesis induced by vascular endothelial growth factor in advanced cervical carcinoma.

Nagai N, Mukai K, Hirata E, Jin HH, Komatsu M, Yunokawa M. Nagai N, et al. Among authors: yunokawa m. Med Oncol. 2008;25(2):214-21. doi: 10.1007/s12032-007-9023-1. Epub 2007 Oct 30. Med Oncol. 2008. PMID: 17968681

9

Prognostic Impact of Circulating Tumor Cell Detected Using a Novel Fluidic Cell Microarray Chip System in Patients with Breast Cancer.

Sawada T, Araki J, Yamashita T, Masubuchi M, Chiyoda T, Yunokawa M, Hoshi K, Tao S, Yamamura S, Yatsushiro S, Abe K, Kataoka M, Shimoyama T, Maeda Y, Kuroi K, Tamura K, Sawazumi T, Minami H, Suda Y, Koizumi F. Sawada T, et al. Among authors: yunokawa m. EBioMedicine. 2016 Sep;11:173-182. doi: 10.1016/j.ebiom.2016.07.027. Epub 2016 Jul 27. EBioMedicine. 2016. PMID: 27495793 Free PMC article.

10

The notorious "drug lag" for oncology drugs in Japan.

Yonemori K, Hirakawa A, Ando M, Hirata T, Yunokawa M, Shimizu C, Katsumata N, Tamura K, Fujiwara Y. Yonemori K, et al. Among authors: yunokawa m. Invest New Drugs. 2011 Aug;29(4):706-12. doi: 10.1007/s10637-011-9638-0. Epub 2011 Feb 1. Invest New Drugs. 2011. PMID: 21286780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page